Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001104659-22-042642
Filing Date
2022-04-05
Accepted
2022-04-05 12:26:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B2 tm225911d7_424b2.htm 424B2 141043
2 GRAPHIC tm225911d7_424b2img001.jpg GRAPHIC 6920
  Complete submission text file 0001104659-22-042642.txt   151744
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-262614 | Film No.: 22805839
SIC: 2836 Biological Products, (No Diagnostic Substances)